Mark E. Strome - 14 Nov 2022 SCHEDULE 13G/A Report for Cue Biopharma, Inc. Common Stock, $0.001 par value per share (CUE)

Filing Manager
Mark E. Strome
Reporting Manager
Mark E. Strome
Security
Cue Biopharma, Inc. Common Stock, $0.001 par value per share
Symbol
CUE
Shares outstanding
43,411,663 shares
Disclosed Ownership
2,166,242 shares
Ownership
5%
Form type
SCHEDULE 13G/A
Filing time
16 May 2025, 16:01:24 UTC
Date of event
14 Nov 2022
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Mark E. Strome disclosed 5% ownership in Cue Biopharma, Inc. Common Stock, $0.001 par value per share (CUE) on 14 Nov 2022."

Quick Takeaways

  • Mark E. Strome filed SCHEDULE 13G/A for Cue Biopharma, Inc. Common Stock, $0.001 par value per share (CUE).
  • Disclosed ownership: 5%.
  • Date of event: 14 Nov 2022.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 16 May 2025, 16:01.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Mark E. Strome 5% 2,166,242 50,229 2,116,013 /s/ Mark E. Strome Mark E. Strome
Strome Mezzanine Fund, LP 0.11% 46,103 0 46,103 /s/ Mark E. Strome President of Strome Group, Inc., the general partner of Strome Investment Management, LP, the general partner of Strome Mezzanine Fund, LP
Strome Mezzanine Fund II, LP 4.4% 1,907,281 0 1,907,281 /s/ Mark E. Strome President of Strome Group, Inc., the general partner of Strome Investment Management, LP, the general partner of Strome Mezzanine Fund II, LP
Strome Dynasty, LLC. 0.38% 162,629 0 162,629 /s/ Mark E. Strome Manager

Sponsored